Berkowitz Noah bought IOVA

September 30, 2026 · Form 4 insider transaction

Berkowitz Noah bought 135,000 shares of Iovance Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
135,000
Price
$0.00
Total value
N/A
Role—
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 30, 2026
Filing dateOctober 2, 2026
Shares owned after135,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

View the original Form 4 on SEC EDGAR